Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | +5.24% | +11.11% | -97.81% |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
May. 15 | Transcript : Panbela Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.94M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.09
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Panbela Therapeutics, Inc.
1 day | +5.24% | ||
1 week | +11.11% | ||
1 month | -2.44% | ||
3 months | -68.50% | ||
6 months | -96.66% | ||
Current year | -97.81% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.4 | +5.24% | 28,390 |
24-05-30 | 0.3801 | -4.49% | 34,107 |
24-05-29 | 0.398 | -7.45% | 12,358 |
24-05-28 | 0.43 | +19.44% | 16,994 |
24-05-24 | 0.36 | -5.26% | 43,548 |
Delayed Quote OTC Markets, May 31, 2024 at 03:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.81% | 1.94M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- SNBP Stock